Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation (via PR Newswire)– Findings Published in the Journal of the American College of Cardiology Demonstrate Significant Improvements in Day-to-Day Quality of Life – Study in EuroIntervention Shows Similar Benefits in Both Elderly and Younger Patients ABBOTT PARK, Ill., June 4, 2013 /PRNewswire/ — Abbott today announced…
published: June 7, 2013 in: Abbott, Clinical Studies/Trials